Bringing the fundamentals into focus…
Back to Aldeyra Therapeutics, Inc.
How Aldeyra Therapeutics, Inc. stacks up
ALDX · against 32 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #19 of 33 · scores higher than 22% of peers
Bars: peers in each 10-point band of the valuation score15 peers with a valuation score of 0–9, including ALDX · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -215.7% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -61.5% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -58.8% vs peer median 0.0%
Metric by metric
Position: dot = ALDX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ALDX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 29 reported | -61.2% | -30.3% | 32% | 30% | |
| EBITDA yieldHigher is better · 39 reported | -1116.6% | -13.3% | 0% | 50% | |
| Free cash flow yieldHigher is better · 22 reported | -58.8% | -22.6% | 19% | 20% | |
| Book yieldHigher is better · 34 reported | 101.1% | 96.8% | 55% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around ALDX| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 272M HKD (≈$35M) | 97 | 59 | |
| 2 | 277M MYR (≈$61M) | 96 | 67 | |
| 3 | 376M BRL (≈$68M) | 90 | 56 | |
| 4 | 5.6B JPY (≈$38M) | 88 | 55 | |
| 5 | 211M MYR (≈$46M) | 74 | 65 | |
| 12 | 83.8B KRW (≈$60M) | 30 | 54 | |
| 12 | 74.0B KRW (≈$53M) | 30 | 34 | |
| 12 | 84M CAD (≈$61M) | 30 | 24 | |
| 12 | 63M EUR (≈$70M) | 30 | 46 | |
| 19 | 37M USD | 8 | 21 | |
| 19 | 250M SEK (≈$25M) | 8 | 44 | |
| 19 | 67M USD | 8 | ||
| 19 | 390.5B IDR (≈$24M) | 8 | 8 | |
| 19 | 298M SEK (≈$30M) | 8 | 48 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score